Cabot (NYSE:CBT) Issues Earnings Results, Misses Estimates By $0.01 EPS

Cabot (NYSE:CBT) issued its earnings results on Monday. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.81 by ($0.01), Briefing.com reports. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.65 EPS. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Trading Up 7.5 %

Shares of CBT opened at $117.02 on Thursday. The firm has a market cap of $6.42 billion, a P/E ratio of 17.36, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. Cabot has a 1 year low of $68.11 and a 1 year high of $117.37. The company has a 50 day simple moving average of $108.69 and a two-hundred day simple moving average of $101.24.

Insider Transactions at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction on Monday, August 26th. The shares were sold at an average price of $106.19, for a total value of $127,534.19. Following the sale, the executive vice president now directly owns 96,000 shares in the company, valued at approximately $10,194,240. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Cabot news, EVP Jeff Ji Zhu sold 1,201 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $106.19, for a total transaction of $127,534.19. Following the completion of the transaction, the executive vice president now owns 96,000 shares in the company, valued at $10,194,240. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Hobart Kalkstein sold 5,457 shares of the stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total value of $548,865.06. Following the transaction, the executive vice president now owns 61,688 shares of the company’s stock, valued at $6,204,579.04. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,665 shares of company stock valued at $4,986,299. 3.07% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

CBT has been the subject of several research analyst reports. JPMorgan Chase & Co. lifted their price objective on Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. UBS Group cut their price objective on Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a research note on Tuesday, August 6th. Finally, Mizuho lifted their price target on shares of Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a report on Tuesday. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $105.00.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.